EGFR and small cell lung carcinoma: In a predefined cohort of EGFR-mutant LUAD patients (n = 65), concurrent loss of TP53 and RB1 conferred a 43-fold increased risk of SCLC transformation, positioning these alterations as early indicators of lineage switching [40].